An Evaluation of Values of ERCC1,K-ras and TP-73 in Tirelizumab Combined with GP Chemotherapy Regimen

An Evaluation of Values of ERCC1,K-ras and TP-73 in Tirelizumab Combined with GP Chemotherapy Regimen

WANG Yafei, ZHANG Zhenjun, SONG Changliang, YANG Qiong

PDF(2524 KB)

Welcome to Labeled Immunoassays and Clinical Medicine website! Share:

PDF(2524 KB)

Labeled Immunoassays and Clinical Medicine ›› 2024, Vol. 31 ›› Issue (3) : 496-501. DOI: 10.11748/bjmy.issn.1006-1703.2024.03.019

Clinical Investigation

An Evaluation of Values of ERCC1,K-ras and TP-73 in Tirelizumab Combined with GP Chemotherapy Regimen

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2024, 31(3): 496-501 https://doi.org/10.11748/bjmy.issn.1006-1703.2024.03.019

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}

{{article.copyrightLicense_en}}

PDF(2524 KB)

Accesses

Citation

Detail

Sections

Recommended

/

〈

〉